Skip to content
Screener

Insmed INSM Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$555K-98.3%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
Net income-$13.2M+95.9%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$28.63B+20.0%
Enterprise value$28.66B+23.8%
P/S25.2×-34.8×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Insmed’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104506-26-000041
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Other liabilities(1,241)(2,982)
Net cash used in operating activities(311,566)(467,657)
Investing activities
Purchase of fixed assets(9,739)(13,554)
Payment of AZ milestone(15,000)
Purchase of marketable securities(399,228)(907,199)
Maturities of marketable securities714,0001,229,000
Net cash provided by investing activities290,033308,247

Item 1C. Consolidated Financial Statements

FAQ

What is Insmed's payments to acquire property, plant, and equipment?
Insmed (INSM) reported payments to acquire property, plant, and equipment of $6.26M in Q2 2026.
How has Insmed's payments to acquire property, plant, and equipment changed year-over-year?
Insmed's payments to acquire property, plant, and equipment increased by 79.6% year-over-year, from $3.48M to $6.26M.
What is the long-term trend for Insmed's payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Insmed's payments to acquire property, plant, and equipment has grown at a 45.4% compound annual growth rate (CAGR), from $7.29M to $32.56M.
What does payments to acquire property, plant, and equipment mean?
Represents the cash outflow used to purchase or construct long-term physical assets, commonly referred to as capital expenditures (CapEx). This metric indicates the company's investment in its infrastructure, manufacturing capacity, or research facilities to support future growth. High levels of investment typically signal a focus on long-term scaling and operational expansion.

Ask your AI about Insmed's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude